)
Hamlet BioPharma (HAMLET) investor relations material
Hamlet BioPharma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved major milestones including completion of three Phase II studies in cancer, infection, and chronic pain, and secured drug production for Phase III studies.
Positive FDA feedback supports pivotal Phase III study for Alpha1H in non-muscle invasive bladder cancer, with advanced preparations underway.
Published successful Phase II results for non-antibiotic treatment of acute cystitis, showing efficacy comparable to antibiotics.
Entered a partnering agreement with ImmunoForge for novel drug delivery technology for tuberculosis treatment.
Ongoing global commercialization and partnership efforts, with a new CEO appointed to lead the next phase.
Financial highlights
Net sales were KSEK 0 for both the quarter and first half, reflecting the pre-revenue stage.
EBITDA for the quarter was KSEK -13,026 (previous year: -11,847); for the first half, KSEK -22,651 (previous year: -19,649).
EBIT for the quarter was KSEK -15,579 (previous year: -14,481); for the first half, KSEK -27,739 (previous year: -24,917).
Net result for the quarter was KSEK -15,431 (previous year: -14,387); for the first half, KSEK -27,588 (previous year: -24,651).
Cash at period end was KSEK 16,638 (previous year: 30,416); equity/assets ratio was 83.6% (previous year: 92.8%).
Outlook and guidance
Immediate goal is to conduct Phase III studies and obtain market approval for Alpha1H in bladder cancer.
Actively exploring additional funding avenues and global partnerships for commercialization.
Strategic focus on advancing preclinical assets and expanding the clinical pipeline.
Next Hamlet BioPharma earnings date
Next Hamlet BioPharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)